124 related articles for article (PubMed ID: 27341130)
1. p63α modulates c-Myc activity via direct interaction and regulation of MM1 protein stability.
Han A; Li J; Li Y; Wang Y; Bergholz J; Zhang Y; Li C; Xiao ZhX
Oncotarget; 2016 Jul; 7(28):44277-44287. PubMed ID: 27341130
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63α down-regulates c-Myc modulator MM1 via E3 ligase HERC3 in the regulation of cell senescence.
Chen Y; Li Y; Peng Y; Zheng X; Fan S; Yi Y; Zeng P; Chen H; Kang H; Zhang Y; Xiao ZX; Li C
Cell Death Differ; 2018 Dec; 25(12):2118-2129. PubMed ID: 29880857
[TBL] [Abstract][Full Text] [Related]
3. Decreased c-Myc mRNA Stability via the MicroRNA 141-3p/AUF1 Axis Is Crucial for p63α Inhibition of Cyclin D1 Gene Transcription and Bladder Cancer Cell Tumorigenicity.
Li X; Tian Z; Jin H; Xu J; Hua X; Yan H; Liufu H; Wang J; Li J; Zhu J; Huang H; Huang C
Mol Cell Biol; 2018 Nov; 38(21):. PubMed ID: 30104251
[TBL] [Abstract][Full Text] [Related]
4. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
5. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis.
Lee KB; Ye S; Park MH; Park BH; Lee JS; Kim SM
Cancer Lett; 2014 Oct; 353(1):124-32. PubMed ID: 25045846
[TBL] [Abstract][Full Text] [Related]
6. Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.
Mack FA; Patel JH; Biju MP; Haase VH; Simon MC
Mol Cell Biol; 2005 Jun; 25(11):4565-78. PubMed ID: 15899860
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation.
Jaenicke LA; von Eyss B; Carstensen A; Wolf E; Xu W; Greifenberg AK; Geyer M; Eilers M; Popov N
Mol Cell; 2016 Jan; 61(1):54-67. PubMed ID: 26687678
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet B irradiation up-regulates MM1 and induces photoageing of the epidermis.
Zheng X; Chen L; Jin S; Xiong L; Chen H; Hu K; Fan X; Fan S; Li C
Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):395-403. PubMed ID: 33565151
[TBL] [Abstract][Full Text] [Related]
9. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
10. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
11. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
[TBL] [Abstract][Full Text] [Related]
12. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
13. ΔNp63α modulates phosphorylation of p38 MAP kinase in regulation of cell cycle progression and cell growth.
Wang L; Xia W; Chen H; Xiao ZX
Biochem Biophys Res Commun; 2019 Feb; 509(3):784-789. PubMed ID: 30635119
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
17. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
18. Mnt-Max to Myc-Max complex switching regulates cell cycle entry.
Walker W; Zhou ZQ; Ota S; Wynshaw-Boris A; Hurlin PJ
J Cell Biol; 2005 May; 169(3):405-13. PubMed ID: 15866886
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
